|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1650 Diagonal Road |
Address2 |
|
| City | ALEXANDRIA |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1386-12
|
||||||||
|
6. House ID# 321810000
|
||||||||
| TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Jonah Scharf |
Date | 4/20/2023 2:34:56 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
January 23, 2023 coalition letter to all Members of the House and Senate urging Congress to hold hearings and work with stakeholders to enact a long-term fix to the Medicare physician payment system.
January 30, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure expressing ongoing concern with network adequacy in Marketplace plans and other issues including Part 156.
February 13, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure providing feedback on the proposed policy changes for Medicare Advantage Organizations and their impacts on access to specialty care.
February 13, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure urging CMS to finalize improvement of the coverage criteria used in medical necessity determinations, ensure a clinically sound foundation for Prior Authorization programs, and protect access to care.
February 21, 2023 coalition letter to all members of the House and Senate expressing support for proposed rules the Food and Drug Administration has issued to prohibit manufacture and sale of menthol cigarettes and flavored cigars.
March 13, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure providing feedback on proposed policy changes to advance interoperability and improve prior authorization.
March 13, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure commenting on the Notice of Proposed Rulemaking outlining proposals to advance interoperability and improve prior authorization in Medicare Advantage plans, state Medicaid agencies and Medicaid managed care plans, CHIP agencies, and issuers of Qualified Health Plans on Federally Facilitated Exchanges.
March 15, 2023 coalition letter to Speaker Kevin McCarthy, Minority Leader Hakeem Jeffries, Majority Leader Chuck Schumer, and Minority Leader Mitch McConnell urging Congress to provide an annual inflation-based payment update based on the full Medicare Economic Index.
March 16, 2023 coalition letter to Rep. Robert Aderholt and Rep. Rosa DeLauro urging their committee to increase funding for the Centers for Disease Control and Preventions Office on Smoking and Health by $63.5 million, for a total of $310 million.
March 16, 2023 coalition letter to Senator Tammy Baldwin and Senator Shelley Moore-Capito urging their committee to increase funding for the Centers for Disease Control and Preventions Office on Smoking and Health by $63.5 million, for a total of $310 million.
March 20, 2023 coalition letter to Senator Bernie Sanders and Senator Bill Cassidy providing information related to the drivers of health care workforce shortages and potential solutions to such shortages.
March 29, 2023 coalition letter to Senator Bernie Sanders, Senator Bob Casey, Senator Bill Cassidy, and Senator Mitt Romney urging them to ensure Federal law provides medical service volunteers who cross state lines to assist with the response to a national emergency, major disaster, or a public health emergency with adequate protection as provided in the bipartisan Good Samaritan Health Professionals Act.
Issues pertaining to scope of practice legislation, in general.
Issues pertaining to prior authorization, in general.
Issues pertaining to the Early Hearing Detection and Intervention Program, in general.
Issues pertaining to Medicare physician reimbursement, related to H.R. 2474, and in general.
Issues related to hearing healthcare, in general.
Issues pertaining to health information technology and electronic health records, in general.
Issues pertaining to Graduate Medical Education, in general.
Issues pertaining to COVID-19, in general.
Issues pertaining to healthcare liability reform, in general.
Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Federal Trade Commission (FTC), Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
January 23, 2023 coalition letter to all Members of the House and Senate urging Congress to hold hearings and work with stakeholders to enact a long-term fix to the Medicare physician payment system.
January 30, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure expressing ongoing concern with network adequacy in Marketplace plans and other issues including Part 156.
February 13, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure providing feedback on the proposed policy changes for Medicare Advantage Organizations and their impacts on access to specialty care.
February 13, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure urging CMS to finalize improvement of the coverage criteria used in medical necessity determinations, ensure a clinically sound foundation for Prior Authorization programs, and protect access to care.
March 13, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure providing feedback on proposed policy changes to advance interoperability and improve prior authorization.
March 13, 2023 coalition letter to CMS Administrator Chiquita Brooks-LaSure commenting on the Notice of Proposed Rulemaking outlining proposals to advance interoperability and improve prior authorization in Medicare Advantage plans, state Medicaid agencies and Medicaid managed care plans, CHIP agencies, and issuers of Qualified Health Plans on Federally Facilitated Exchanges.
March 15, 2023 coalition letter to Speaker Kevin McCarthy, Minority Leader Hakeem Jeffries, Majority Leader Chuck Schumer, and Minority Leader Mitch McConnell urging Congress to provide an annual inflation-based payment update based on the full Medicare Economic Index.
Issues pertaining to scope of practice legislation, in general.
Issues pertaining to prior authorization, in general.
Issues pertaining to the Early Hearing Detection and Intervention Program, in general.
Issues pertaining to Medicare physician reimbursement, related to H.R. 2474, and in general.
Issues related to hearing healthcare, in general.
Issues pertaining to health information technology and electronic health records, in general.
Issues pertaining to COVID-19, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
February 21, 2023 coalition letter to all members of the House and Senate expressing support for proposed rules the Food and Drug Administration has issued to prohibit manufacture and sale of menthol cigarettes and flavored cigars.
March 16, 2023 coalition letter to Rep. Robert Aderholt and Rep. Rosa DeLauro urging their committee to increase funding for the Centers for Disease Control and Preventions Office on Smoking and Health by $63.5 million, for a total of $310 million.
March 16, 2023 coalition letter to Senator Tammy Baldwin and Senator Shelley Moore-Capito urging their committee to increase funding for the Centers for Disease Control and Preventions Office on Smoking and Health by $63.5 million, for a total of $310 million.
Issues pertaining to tobacco control, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
March 16, 2023 coalition letter to Rep. Robert Aderholt and Rep. Rosa DeLauro urging their committee to increase funding for the Centers for Disease Control and Preventions Office on Smoking and Health by $63.5 million, for a total of $310 million.
March 16, 2023 coalition letter to Senator Tammy Baldwin and Senator Shelley Moore-Capito urging their committee to increase funding for the Centers for Disease Control and Preventions Office on Smoking and Health by $63.5 million, for a total of $310 million.
Issues pertaining to increased funding for the Centers for Disease Control and Prevention's Office on Smoking and Health for fiscal year 2023, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |